Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
According to AddLife AB, org. no. 556995-8126, ("AddLife") Articles of Association, the owner of Class A shares has the right to request that the share be converted into Class B shares. At the request of shareholders, 5,340 Class A shares were converted to 5,340 Class B shares.
Following the conversion, the total number of shares and votes in AddLife as of June 28, 2024, amounts to 122,450,250 shares and 163,938,414 votes, respectively. 4,609,796 of these shares are Class A shares, representing 46,097,960 votes, and 117,840,454 are Class B shares, representing 117,840,454 votes. AddLife's share capital and the share's quota value are unchanged.
For more information, contact;
Fredrik Dalborg, CEO, fredrik.dalborg@add.life,+46 70 516 09 01
Christina Rubenhag, CFO, christina.rubenhag@add.life,+46 70 546 72 22
www.add.life
AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has about 2,300 employees in some 85 operating subsidiaries. The Group currently has net sales of approximately SEK 10 billion. AddLife shares are listed on Nasdaq Stockholm.
This information is information that AddLife AB is obliged to make public pursuant to the Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact persons set out above, on 28 June 2024 at 2.00 p.m (CET).